0
Upcoming Allied Market Research
2023
Small Molecule Api Market

Small Molecule API Market

Size, Share, Competitive Landscape and Trend Analysis Report by Product (Biological Procedures, Chemical Process), by Type (Contract, Captive), by Application (Ophthalmology, Cardiovascular, Metabolic, Dermatology, Respiratory, Urology, Others) and by End User (Hospitals, Ambulatory Surgical Centers, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

Report Code: A12359
Pages: NA
Tables: NA
Charts: NA
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.

 

Small active pharmaceutical ingredients (API) molecule is an organic component with low molecular weight. It is an active ingredient used in pharmaceuticals and biological procedures. In addition, API can be used as a combination in finished pharmaceutical products. Being a vital element, its requirement is high in the pharmaceutical industry. The molecule is effective in the diagnosis, treatment, and prevention of various diseases. Small molecules may be used as research tools to probe biological function as well as lead in the development of new therapeutic agents. Some can obstruct a specific function of a protein or interrupt protein-protein interactions.

The molecular value of the small API is approximately 900 Daltons and size on the order of 1 nm. Due to its low molecular weight, the body absorbs this active solution quickly.

COVID-19 Impact analysis

Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future, owing to the demand for vaccine and treatment drugs for COVID-19. This, in turn, is expected to have a significant impact on the small molecule API market.

Top Impacting Factors

  • The rising prevalence of chronic diseases such as cardiovascular, cancer, and infectious diseases and the growing geriatric population are driving factors for the small molecule API market.
  • Patent’s expiry of the top-selling pharmaceutical company is acting as a key driver of the global small molecule API market growth.
  • Increasing awareness in the major worldwide population regarding the overall health and advantages of small molecule API is fueling the market growth.
  • In addition to this, increasing technological developments in the manufacturing sector are fueling the growth of the global small molecule API market.
  • However, several stringent regulations by the government regarding small molecule usage restrict the market growth.
  • Conversely, increasing government funding and policies in the healthcare sector is expected to offer massive growth opportunities for this market.

Market Trends

New product launches to flourish the market

In March 2019, GHO Capital, a European healthcare investor, acquired a majority stake in Sterling Pharma Solutions, a manufacturer of small molecule APIs.

In January 2019, Cambrex Corporation, a manufacturer of small molecule innovator and generic APIs, acquired Avista Pharma Solutions, a contract manufacturing organization from Ampersand Capital Partners. The acquisition is expected to provide Cambrex the access to its manufacturing facilities.

In November 2019, Novartis announced the acquisition of CellforCure—a France-based CDMO—for producing molecules in-house, which was earlier contracted to CellforCure. These initiatives undertaken by key players are anticipated to boost the market growth.

In January 2020, Merck announced its strategic collaboration for the oncology platform with Taiho Pharmaceutical Co, Ltd. and Taiho Pharmaceutical Co., Ltd. to expand its focus on small molecule inhibitors for cancer research.

Key Benefits of the Report

  • This study presents the analytical depiction of the small molecule API along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the small molecule API market share.
  • The current market is quantitatively analyzed to highlight the small molecule API market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the small molecule API market.
  • The report provides a detailed market analysis depending on competitive intensity and how the competition will take shape in coming years.

Questions answered in the Small Molecule API Report

  • Who are the leading market players active in the small molecule API market?
  • What current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What future projections would help in taking further strategic steps?
  • What is "small molecule API "?
  • What is "small molecule API” market prediction in the future?
  • Who are the leading global players in the "small molecule API” market?
  • What are the current trends and predicted trends?
  • What are the key benefits of the "small molecule API” market report?

Small Molecule API Market Report Highlights

Aspects Details
By Product
  • Biological Procedures
  • Chemical Process
By Type
  • Contract
  • Captive
By Application
  • Ophthalmology
  • Cardiovascular
  • Metabolic
  • Dermatology
  • Respiratory
  • Urology
  • Others
By End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players Teva Pharmaceutical Industries Ltd., AstraZeneca Plc., Cambrex Corporation, Pfizer, Inc., Baxter International Inc., Boehringer Ingelheim International GmbH, Celgene Corporation, BASF SE, Sanofi S.A., Sun Pharmaceutical Industries Ltd.
 

Loading Table Of Content...


 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Purchase Options

Call or Email Us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Small Molecule Api Market

Start reading.
This Report and over 71,323+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,930
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

Related Reports
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of the scope of the report to exactly meet your needs

Targeted Market View

Targeted market view to provide pertinent information and save time for readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of the scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save the time of readers